Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 012708
Company: MEDPOINTE PHARM HLC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DIUTENSEN-R METHYCLOTHIAZIDE; RESERPINE 2.5MG;0.1MG TABLET;ORAL Discontinued None No No
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/30/1975 SUPPL-9 Labeling

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English